Abstract
The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1471-1474 |
| Number of pages | 4 |
| Journal | Annals of Surgical Oncology |
| Volume | 17 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2010 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Oncology
Cite this
The american joint committee on cancer : The 7th edition of the AJCC cancer staging manual and the future of TNM. / Edge, Stephen B.; Compton, Carolyn.
In: Annals of Surgical Oncology, Vol. 17, No. 6, 06.2010, p. 1471-1474.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The american joint committee on cancer
T2 - The 7th edition of the AJCC cancer staging manual and the future of TNM
AU - Edge, Stephen B.
AU - Compton, Carolyn
PY - 2010/6
Y1 - 2010/6
N2 - The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.
AB - The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.
UR - http://www.scopus.com/inward/record.url?scp=77954818058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954818058&partnerID=8YFLogxK
U2 - 10.1245/s10434-010-0985-4
DO - 10.1245/s10434-010-0985-4
M3 - Article
C2 - 20180029
AN - SCOPUS:77954818058
VL - 17
SP - 1471
EP - 1474
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
SN - 1068-9265
IS - 6
ER -